- The COVID-19 pandemic has sickened more than 78 million people worldwide, leading to the deaths of more than 1.7 million people
- The pandemic has hammered businesses as society has attempted to lessen human contact in order to limit the spread of the virus responsible for the illnesses, especially as a growing number of employees of the stressed companies have needed sick leave
- Autonomous Security Robot (“ASR”) developer Knightscope has enhanced its artificial intelligence-equipped sentries with elevated body temperature detection to help companies measure body temperatures of employees and visitors entering their facilities
- The feature will help client companies protect their employees from virus transmission on their premises, potentially reducing liability concerns in the process
As vaccines to combat the novel coronavirus begin to rollout across the country, Americans are acknowledging that it may take weeks or a number of months before a significant reduction of the pandemic’s threat takes place (https://ibn.fm/px2Cy).
Autonomous security developer Knightscope has noted that one benefit of its robotic security teams patrolling select businesses and agencies across five time zones is that they are “immune and have been continuing to patrol across the country despite the pandemic” (https://ibn.fm/5356f).
Now, the robots are also helping to provide a sense of COVID confidence by enabling elevated body temperature detection from wherever the sentries are located.
“The Centers for Disease Control and Prevention indicates that a person with a temperature of 100.4 degrees or greater has a ‘fever,’ a symptom of COVID-19,” a recent Knightscope announcement states (https://ibn.fm/r5Z8W). “In an effort to help combat the spread of COVID-19, Knightscope developed a way for its clients to measure body temperatures of employees and visitors entering a facility.”
The Pew Research Center reported in March that 24 percent of workers didn’t have access to any kind of paid sick leave prior to the pandemic, as noted in The Deseret News (https://ibn.fm/Z4f6T). Only 13 states currently require employers to offer paid sick leave. Fewer states passed temporary new measures in response to the coronavirus. But the need for sick workers to stay home if they’ve been infected means that businesses are not only under pressure as staffing levels become more critical, but also in dealing with the financial realities that their employees are wrestling with.
Knightscope’s new solution ultimately protects companies and their employees from the threat of virus transmission in the workplace as well as from the traditional external safety issues surrounding potential crime, fire and property damage matters.
“Our long-term ambition is to make the United States of America the safest country in the world,” the company’s website states.
For more information, visit the company’s website at www.Knightscope.com.
Visit www.Knightscope.com/invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO.
DISCLAIMER: You should read the Offering Circular and risks related to this offering before investing. This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
